GLP1R and metabolic dysfunction-associated steatohepatitis: In the liver, GLP-1 also reduces hepatic steatosis and inflammation and can additionally attenuate hepatocyte injury in preclinical studies with models of non-alcoholic steatohepatitis (NASH).